• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞外容积分数的左心室纤维化与导管消融术后房颤复发风险

Left ventricular fibrosis by extracellular volume fraction and the risk of atrial fibrillation recurrence after catheter ablation.

作者信息

Li Songnan, Zhao Lei, Ma Xiaohai, Bai Rong, Tian Jie, Selvanayagam Joseph B

机构信息

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

出版信息

Cardiovasc Diagn Ther. 2019 Dec;9(6):578-585. doi: 10.21037/cdt.2019.12.03.

DOI:10.21037/cdt.2019.12.03
PMID:32038947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6987514/
Abstract

BACKGROUND

Left ventricular (LV) extracellular volume fraction (ECV) provides prognostic information in patients with variety of cardiomyopathies. However, data on the clinical significance of LV ECV in patients with atrial fibrillation (AF), especially in patients without replacement fibrosis are sparse. This study sought to investigate whether the presence of LV fibrosis identified by cardiac magnetic resonance (CMR) ECV quantification would independently predict the recurrence of AF after first catheter ablation (CA) in patients with AF.

METHODS

A total of 130 consecutive patients who were referred for CA of AF underwent CMR examination prior to ablation. LV function, T1 mapping derived LV ECV, LV late gadolinium enhancement (LGE) were assessed. Patients were followed for arrhythmia recurrence after the CA procedure.

RESULTS

Of 130 AF patients, 65 patients had paroxysmal AF, and 65 patients had persistent AF. There were 50 AF recurrences over a median follow-up period of 13 months. LV ECV were significantly higher in patients with recurrent AF compared to those with no recurrence (30.4%±3.3% . 27.4%±2.9%, P<0.001). In multivariable model, gender (HR: 0.348, 95% CI: 0.174-0.697, P=0.003), body mass index (BMI) (HR: 1.159, 95% CI: 1.050-1.279, P=0.003), AF duration (HR: 1.006, 95% CI: 1.001-1.011, P=0.017), and LV ECV (HR: 1.158, 95% CI: 1.071-1.251, P=0.000) were significantly associated with AF recurrence. In subgroup of patients without LGE, gender, BMI, AF duration and LV ECV were still the independent predictors of AF recurrence.

CONCLUSIONS

LV ECV expansion is associated with AF recurrence after CA and is a strong independent predictor of AF recurrence.

摘要

背景

左心室(LV)细胞外容积分数(ECV)可为多种心肌病患者提供预后信息。然而,关于心房颤动(AF)患者左心室ECV临床意义的数据,尤其是在无替代纤维化患者中的数据较为稀少。本研究旨在探讨通过心脏磁共振(CMR)ECV定量识别的左心室纤维化是否能独立预测AF患者首次导管消融(CA)后AF的复发。

方法

共有130例因AF接受CA治疗的连续患者在消融前接受了CMR检查。评估左心室功能、T1映射得出的左心室ECV、左心室延迟钆增强(LGE)。对患者进行CA术后心律失常复发情况的随访。

结果

130例AF患者中,65例为阵发性AF,65例为持续性AF。在中位随访期13个月内有50例AF复发。复发AF患者的左心室ECV显著高于未复发患者(30.4%±3.3% 对27.4%±2.9%,P<0.001)。在多变量模型中,性别(HR:0.348,95%CI:0.174 - 0.697,P = 0.003)、体重指数(BMI)(HR:1.159,95%CI:1.050 - 1.279,P = 0.003)、AF持续时间(HR:1.006,95%CI:1.001 - 1.011,P = 0.017)和左心室ECV(HR:1.158,95%CI:1.071 - 1.251,P = 0.000)与AF复发显著相关。在无LGE的患者亚组中,性别、BMI、AF持续时间和左心室ECV仍是AF复发的独立预测因素。

结论

左心室ECV扩大与CA术后AF复发相关,是AF复发的强有力独立预测因素。

相似文献

1
Left ventricular fibrosis by extracellular volume fraction and the risk of atrial fibrillation recurrence after catheter ablation.基于细胞外容积分数的左心室纤维化与导管消融术后房颤复发风险
Cardiovasc Diagn Ther. 2019 Dec;9(6):578-585. doi: 10.21037/cdt.2019.12.03.
2
Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.心肌细胞外容积扩张与肺静脉隔离术后房颤复发风险
JACC Cardiovasc Imaging. 2014 Jan;7(1):1-11. doi: 10.1016/j.jcmg.2013.08.013. Epub 2013 Nov 27.
3
Incidental LV LGE on CMR Imaging in Atrial Fibrillation Predicts Recurrence After Ablation Therapy.磁共振成像中左心室 LGE 与房颤消融术后复发的相关性。
JACC Cardiovasc Imaging. 2015 Jul;8(7):793-800. doi: 10.1016/j.jcmg.2015.03.008. Epub 2015 Jun 17.
4
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.窦性心律可恢复心肌病患者的心室功能,这些患者在因房颤行导管消融术时心脏磁共振成像上无晚期钆增强。
Heart Rhythm. 2013 Sep;10(9):1334-9. doi: 10.1016/j.hrthm.2013.06.019. Epub 2013 Jun 27.
5
Left ventricular extracellular volume expansion does not predict recurrence of atrial fibrillation following catheter ablation.左心室细胞外容积扩张不能预测导管消融后心房颤动的复发。
Pacing Clin Electrophysiol. 2020 Feb;43(2):159-166. doi: 10.1111/pace.13853. Epub 2020 Jan 9.
6
Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.T1 mapping 测量的细胞外容积分数可预测非缺血性扩张型心肌病伴心房颤动患者经导管消融治疗后左心室射血分数的改善。
Int J Cardiovasc Imaging. 2021 Aug;37(8):2535-2543. doi: 10.1007/s10554-021-02219-x. Epub 2021 Mar 16.
7
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .心房颤动患者中晚期钆增强左心室心肌瘢痕的发生率、模式和预后价值。
J Am Coll Cardiol. 2013 Dec 10;62(23):2205-14. doi: 10.1016/j.jacc.2013.07.067. Epub 2013 Aug 28.
8
Reverse left ventricular structural remodeling after catheter ablation of atrial fibrillation in patients with preserved left ventricular function: Insights from cardiovascular magnetic resonance native T1 mapping.经导管消融治疗左室射血分数保留的心房颤动患者的左心室逆向重构:心血管磁共振 native T1 mapping 的新见解。
Heart Rhythm. 2019 Mar;16(3):424-432. doi: 10.1016/j.hrthm.2018.09.016. Epub 2018 Sep 21.
9
Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.阵发性心房颤动患者肺静脉隔离术后左心室固有T1时间与心房颤动复发风险
Int J Cardiol. 2016 Jan 15;203:848-54. doi: 10.1016/j.ijcard.2015.11.073. Epub 2015 Nov 11.
10
Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation.心脏 MRI 上 T₁ mapping 测量的弥漫性心室纤维化可预测房颤导管消融的成功率。
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):834-40. doi: 10.1161/CIRCEP.114.001479. Epub 2014 Aug 20.

引用本文的文献

1
Myocardial extracellular volume fraction estimations using late enhancement CT in patients with atrial fibrillation: a comparative study with cardiac MR.使用延迟增强CT对心房颤动患者进行心肌细胞外容积分数评估:与心脏磁共振成像的对比研究
Int J Cardiovasc Imaging. 2025 Mar;41(3):419-426. doi: 10.1007/s10554-024-03316-3. Epub 2025 Jan 30.
2
Value of Imaging in the Non-Invasive Prediction of Recurrence after Catheter Ablation in Patients with Atrial Fibrillation: An Up-to-Date Review.影像学检查在房颤患者导管消融术后复发无创预测中的价值:最新综述
Rev Cardiovasc Med. 2023 Aug 18;24(8):241. doi: 10.31083/j.rcm2408241. eCollection 2023 Aug.
3
Quantification of myocardial extracellular volume without blood sampling.无需采血的心肌细胞外容积定量分析。
Eur Heart J Imaging Methods Pract. 2023 Sep 15;1(2):qyad022. doi: 10.1093/ehjimp/qyad022. eCollection 2023 Sep.
4
Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia.多参数心脏磁共振成像在新输血依赖型地中海贫血中的预后作用
J Clin Med. 2024 Feb 23;13(5):1281. doi: 10.3390/jcm13051281.
5
Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.开发并验证一种新的预测模型,用于预测在第一次射频导管消融治疗中使用尼非卡兰的持续性心房颤动患者的心房颤动复发风险。
Cardiovasc Drugs Ther. 2023 Dec;37(6):1117-1129. doi: 10.1007/s10557-022-07353-9. Epub 2022 Jun 22.

本文引用的文献

1
Impact of Female Sex on Clinical Outcomes in the FIRE AND ICE Trial of Catheter Ablation for Atrial Fibrillation.女性性别对房颤导管消融治疗的 FIRE AND ICE 试验临床结局的影响。
Circ Arrhythm Electrophysiol. 2018 May;11(5):e006204. doi: 10.1161/CIRCEP.118.006204.
2
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
3
Modifiable Risk Factors and Atrial Fibrillation.可改变的风险因素与心房颤动。
Circulation. 2017 Aug 8;136(6):583-596. doi: 10.1161/CIRCULATIONAHA.116.023163.
4
Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case-control study of patients with history of atrial fibrillation.在一项针对有房颤病史患者的病例对照研究中,心房和心室壁出现与纤维化相关的炎症反应的组织学证据。
Europace. 2016 Dec;18(suppl 4):iv156-iv162. doi: 10.1093/europace/euw361.
5
Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation.孤立性心房颤动与左心室能量代谢受损有关,尽管导管消融成功,这种受损情况仍持续存在。
Circulation. 2016 Oct 11;134(15):1068-1081. doi: 10.1161/CIRCULATIONAHA.116.022931. Epub 2016 Sep 14.
6
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27.
7
Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation.采用心率依赖型脉冲序列采样方案的收缩期MOLLI T1映射在心房颤动患者中是可行的。
J Cardiovasc Magn Reson. 2016 Mar 15;18:13. doi: 10.1186/s12968-016-0232-7.
8
State of the Art: Clinical Applications of Cardiac T1 Mapping.现状:心脏 T1 映射的临床应用。
Radiology. 2016 Mar;278(3):658-76. doi: 10.1148/radiol.2016141802.
9
Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.心房颤动患者的心肌纤维化:机制与临床意义。
J Am Coll Cardiol. 2015 Aug 25;66(8):943-59. doi: 10.1016/j.jacc.2015.06.1313.
10
Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.肥胖伴心房颤动患者的心肺适能对心律失常复发的影响:CARDIO-FIT 研究。
J Am Coll Cardiol. 2015 Sep 1;66(9):985-96. doi: 10.1016/j.jacc.2015.06.488. Epub 2015 Jun 22.